Clinical Trials Directory

Trials / Conditions / Non-metastatic Castration-resistant Prostate Cancer

Non-metastatic Castration-resistant Prostate Cancer

8 registered clinical trials studyying Non-metastatic Castration-resistant Prostate Cancer — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingAn Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
NCT06334120
Bayer—
RecruitingPROCARE - PROstate Cancer Real World Evidence Registry
NCT06835218
UroTrials Company (GmbH)—
CompletedAn Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men Wit
NCT06204302
Bayer—
CompletedAn Observational Cohort Study to Describe and Compare the Use of Darolutamide, Enzalutamide and Apalutamide an
NCT06013475
Bayer—
RecruitingA Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Ta
NCT05348876
BayerPhase 4
CompletedAn Observational Study, Called DEAR, to Learn More About Treatment With Darolutamide, Enzalutamide and Apaluta
NCT05362149
Bayer—
CompletedStudy of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic
NCT04666129
Sumitomo Pharma America, Inc.Phase 1
CompletedPhase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
NCT03493945
National Cancer Institute (NCI)Phase 1 / Phase 2